Yunpeng Yang

机构：Sun Yat-sen University, University of California San Diego, Center for Excellence in Brain Science and Intelligence Technology, VA San Diego Healthcare System, Yango University, Yangzhou Vocational University, Sun Yat-sen University Cancer Center, Shanghai Center for Brain Science and Brain-Inspired Technology, Yangzhou University, China National Petroleum Corporation (China) · ORCID：0000-0001-5163-0940

发表论文 370 篇 · 总被引 9843 次 · h-index 49

代表论文

• A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial (2025 · Nature Medicine · 被引 88)
• Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial (2025 · Journal of Hematology & Oncology · 被引 26)
• Discovery of an ene-reductase initiating resveratrol catabolism in gut microbiota and its application in disease treatment (2025 · Cell Reports · 被引 16)
• Murine gut microbial interactions exert antihyperglycemic effects (2025 · The ISME Journal · 被引 8)
• Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial (2025 · Signal Transduction and Targeted Therapy · 被引 7)
• Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial (2024 · Journal of Thoracic Oncology · 被引 7)